Investment Management
Since 20 Jan 2016, Royal Dutch Shell Class A shares in London have climbed more than 60 percent in value and we see them climbing further. We see Brent Crude ultimately trading at $60 per barrel and this will cause Shell to climb in value Shell is unique from other oil exploration and production […]
The FDA has approved Appvie’s Humira (Adalimumab) for the treatment of non-infectious, intermediate, posterior and panuveitis, a group of inflammatory eye diseases and can impact vision. The expanded label, an Orphan Drug indication, marks the 10th approved use for Humira in the US for immune-mediated diseases Humira is also approved in the European Union […]
We are still long ARM Holdings. First Target: 1,200 pence: ARM acquired Apical for $350 million. The Company designs circuits for machine vision that can be embedded in chips developed by ARM’s customers. The company already has 1 billion smartphones shipped with its technology What Can Aprical Do? What they’re able to do is […]
* German Sporting goods maker Adidas plans to open 3,000 new stores in China by 2020, counting on rising affluence and health-awareness in the country to boost its global business. The new stores will bring Adidas’ total to about 12,000 across 2,200 cities in China and the company will focus more on kids’ sports apparel as […]
* Celgene’s Juno Therapeutics, (which it acquired in June 2015 for $1 billion), has reported encouraging results from two early-stage studies assessing two CAR-T candidates in its CD19 program. The results were presented yesterday at ASCO16 in Chicago * Results from a randomized Phase 1/2 study assessing JCAR014 in patients with relapsed/refractory acute lymphoblastic leukemia […]
Sign up our newsletter for FREE financial advice and investment tips delivered to your inbox on weekly basis.
Want to keep in touch with news from Blue Phoenix Financials? Subscribe to our RSS feed using by clicking on the button to the right, or subscribe to our newsletter by filling out the form below.